Stage I melanoma of the limbs. Immediate versus delayed node dissection

U. Veronesi, J. Adamus, D. C. Bandiera, I. O. Brennhovd, E. Caceres, N. Cascinelli, F. Claudio, R. L. Ikonopisov, V. V. Javorskj, S. Kirov, A. Kulakowski, J. Lacour, F. Lejeune, Z. Mechl, A. Morabito, I. Rodé, S. Sergeev, E. van Slooten, K. Szczygiel, N. N. TrapeznikovR. I. Wagner

Research output: Contribution to journalArticle

Abstract

553 patients with stage I malignant melanoma of the limbs entered a prospective randomized clinical trial carried out by the W.H.O. Collaborating Centres for Evaluating of Methods of Diagnosis and Treatment of Melanoma from September 1967 to January 1974. 286 patients were submitted to wide excision of primary and node dissection at the time of appearance of regional lymph node metastases, and 267 to wide excision and immediate node dissection. Survival was identical in the 2 groups. Different subsets of patients were evaluated to assess whether some groups of patients may benefit from immediate node dissection. As regards sex, females had a significantly higher survival rate than males (p ≤0.05), but result were not improved by immediate node dissection. Maximum diameter and elevation of primary melanoma were significantly related to survival but also in these cases immediate node dissection did not achieve better results. 63 patients had an excisional biopsy of their melanoma within 4 weeks before final treatment. This procedure did not worsen survival but immediate node dissection did not improve survival. 273 cases were classified according to histologic type: survival of superficial spreading and nodular melanoma was not different at a statistically significant level after the 2 treatment modalities. 325 cases were considered classifiable according to Clark's levels, out of these 165 were submitted to immediate node dissection. Neither level III nor level IV cases showed higher survival rate after immediate node dissection. Maximum tumor thickness according to Breslow was evaluated in 338 cases; 188 were submitted to wide excision and immediate node dissection. In no clusters of thickness did the enlarged surgical procedure achieve better results. The authors conclude that there is good evidence that in stage I melanoma of the extremities delayed dissection is as effective as the immediate one in the control of the disease if the patient can be kept under strict clinical control. Immediate node dissection is advisable if the quarterly follow-up is not guaranteed, at least for melanomas thicker than 2 mm.

Original languageEnglish
Pages (from-to)373-396
Number of pages24
JournalTumori
Volume66
Issue number3
Publication statusPublished - 1980

Fingerprint

Dissection
Melanoma
Extremities
Survival
Survival Rate
Therapeutics
Randomized Controlled Trials
Lymph Nodes
Neoplasm Metastasis
Biopsy

ASJC Scopus subject areas

  • Cancer Research

Cite this

Veronesi, U., Adamus, J., Bandiera, D. C., Brennhovd, I. O., Caceres, E., Cascinelli, N., ... Wagner, R. I. (1980). Stage I melanoma of the limbs. Immediate versus delayed node dissection. Tumori, 66(3), 373-396.

Stage I melanoma of the limbs. Immediate versus delayed node dissection. / Veronesi, U.; Adamus, J.; Bandiera, D. C.; Brennhovd, I. O.; Caceres, E.; Cascinelli, N.; Claudio, F.; Ikonopisov, R. L.; Javorskj, V. V.; Kirov, S.; Kulakowski, A.; Lacour, J.; Lejeune, F.; Mechl, Z.; Morabito, A.; Rodé, I.; Sergeev, S.; van Slooten, E.; Szczygiel, K.; Trapeznikov, N. N.; Wagner, R. I.

In: Tumori, Vol. 66, No. 3, 1980, p. 373-396.

Research output: Contribution to journalArticle

Veronesi, U, Adamus, J, Bandiera, DC, Brennhovd, IO, Caceres, E, Cascinelli, N, Claudio, F, Ikonopisov, RL, Javorskj, VV, Kirov, S, Kulakowski, A, Lacour, J, Lejeune, F, Mechl, Z, Morabito, A, Rodé, I, Sergeev, S, van Slooten, E, Szczygiel, K, Trapeznikov, NN & Wagner, RI 1980, 'Stage I melanoma of the limbs. Immediate versus delayed node dissection', Tumori, vol. 66, no. 3, pp. 373-396.
Veronesi U, Adamus J, Bandiera DC, Brennhovd IO, Caceres E, Cascinelli N et al. Stage I melanoma of the limbs. Immediate versus delayed node dissection. Tumori. 1980;66(3):373-396.
Veronesi, U. ; Adamus, J. ; Bandiera, D. C. ; Brennhovd, I. O. ; Caceres, E. ; Cascinelli, N. ; Claudio, F. ; Ikonopisov, R. L. ; Javorskj, V. V. ; Kirov, S. ; Kulakowski, A. ; Lacour, J. ; Lejeune, F. ; Mechl, Z. ; Morabito, A. ; Rodé, I. ; Sergeev, S. ; van Slooten, E. ; Szczygiel, K. ; Trapeznikov, N. N. ; Wagner, R. I. / Stage I melanoma of the limbs. Immediate versus delayed node dissection. In: Tumori. 1980 ; Vol. 66, No. 3. pp. 373-396.
@article{abc1b54d00e14fd6b30fb7adc514e302,
title = "Stage I melanoma of the limbs. Immediate versus delayed node dissection",
abstract = "553 patients with stage I malignant melanoma of the limbs entered a prospective randomized clinical trial carried out by the W.H.O. Collaborating Centres for Evaluating of Methods of Diagnosis and Treatment of Melanoma from September 1967 to January 1974. 286 patients were submitted to wide excision of primary and node dissection at the time of appearance of regional lymph node metastases, and 267 to wide excision and immediate node dissection. Survival was identical in the 2 groups. Different subsets of patients were evaluated to assess whether some groups of patients may benefit from immediate node dissection. As regards sex, females had a significantly higher survival rate than males (p ≤0.05), but result were not improved by immediate node dissection. Maximum diameter and elevation of primary melanoma were significantly related to survival but also in these cases immediate node dissection did not achieve better results. 63 patients had an excisional biopsy of their melanoma within 4 weeks before final treatment. This procedure did not worsen survival but immediate node dissection did not improve survival. 273 cases were classified according to histologic type: survival of superficial spreading and nodular melanoma was not different at a statistically significant level after the 2 treatment modalities. 325 cases were considered classifiable according to Clark's levels, out of these 165 were submitted to immediate node dissection. Neither level III nor level IV cases showed higher survival rate after immediate node dissection. Maximum tumor thickness according to Breslow was evaluated in 338 cases; 188 were submitted to wide excision and immediate node dissection. In no clusters of thickness did the enlarged surgical procedure achieve better results. The authors conclude that there is good evidence that in stage I melanoma of the extremities delayed dissection is as effective as the immediate one in the control of the disease if the patient can be kept under strict clinical control. Immediate node dissection is advisable if the quarterly follow-up is not guaranteed, at least for melanomas thicker than 2 mm.",
author = "U. Veronesi and J. Adamus and Bandiera, {D. C.} and Brennhovd, {I. O.} and E. Caceres and N. Cascinelli and F. Claudio and Ikonopisov, {R. L.} and Javorskj, {V. V.} and S. Kirov and A. Kulakowski and J. Lacour and F. Lejeune and Z. Mechl and A. Morabito and I. Rod{\'e} and S. Sergeev and {van Slooten}, E. and K. Szczygiel and Trapeznikov, {N. N.} and Wagner, {R. I.}",
year = "1980",
language = "English",
volume = "66",
pages = "373--396",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Stage I melanoma of the limbs. Immediate versus delayed node dissection

AU - Veronesi, U.

AU - Adamus, J.

AU - Bandiera, D. C.

AU - Brennhovd, I. O.

AU - Caceres, E.

AU - Cascinelli, N.

AU - Claudio, F.

AU - Ikonopisov, R. L.

AU - Javorskj, V. V.

AU - Kirov, S.

AU - Kulakowski, A.

AU - Lacour, J.

AU - Lejeune, F.

AU - Mechl, Z.

AU - Morabito, A.

AU - Rodé, I.

AU - Sergeev, S.

AU - van Slooten, E.

AU - Szczygiel, K.

AU - Trapeznikov, N. N.

AU - Wagner, R. I.

PY - 1980

Y1 - 1980

N2 - 553 patients with stage I malignant melanoma of the limbs entered a prospective randomized clinical trial carried out by the W.H.O. Collaborating Centres for Evaluating of Methods of Diagnosis and Treatment of Melanoma from September 1967 to January 1974. 286 patients were submitted to wide excision of primary and node dissection at the time of appearance of regional lymph node metastases, and 267 to wide excision and immediate node dissection. Survival was identical in the 2 groups. Different subsets of patients were evaluated to assess whether some groups of patients may benefit from immediate node dissection. As regards sex, females had a significantly higher survival rate than males (p ≤0.05), but result were not improved by immediate node dissection. Maximum diameter and elevation of primary melanoma were significantly related to survival but also in these cases immediate node dissection did not achieve better results. 63 patients had an excisional biopsy of their melanoma within 4 weeks before final treatment. This procedure did not worsen survival but immediate node dissection did not improve survival. 273 cases were classified according to histologic type: survival of superficial spreading and nodular melanoma was not different at a statistically significant level after the 2 treatment modalities. 325 cases were considered classifiable according to Clark's levels, out of these 165 were submitted to immediate node dissection. Neither level III nor level IV cases showed higher survival rate after immediate node dissection. Maximum tumor thickness according to Breslow was evaluated in 338 cases; 188 were submitted to wide excision and immediate node dissection. In no clusters of thickness did the enlarged surgical procedure achieve better results. The authors conclude that there is good evidence that in stage I melanoma of the extremities delayed dissection is as effective as the immediate one in the control of the disease if the patient can be kept under strict clinical control. Immediate node dissection is advisable if the quarterly follow-up is not guaranteed, at least for melanomas thicker than 2 mm.

AB - 553 patients with stage I malignant melanoma of the limbs entered a prospective randomized clinical trial carried out by the W.H.O. Collaborating Centres for Evaluating of Methods of Diagnosis and Treatment of Melanoma from September 1967 to January 1974. 286 patients were submitted to wide excision of primary and node dissection at the time of appearance of regional lymph node metastases, and 267 to wide excision and immediate node dissection. Survival was identical in the 2 groups. Different subsets of patients were evaluated to assess whether some groups of patients may benefit from immediate node dissection. As regards sex, females had a significantly higher survival rate than males (p ≤0.05), but result were not improved by immediate node dissection. Maximum diameter and elevation of primary melanoma were significantly related to survival but also in these cases immediate node dissection did not achieve better results. 63 patients had an excisional biopsy of their melanoma within 4 weeks before final treatment. This procedure did not worsen survival but immediate node dissection did not improve survival. 273 cases were classified according to histologic type: survival of superficial spreading and nodular melanoma was not different at a statistically significant level after the 2 treatment modalities. 325 cases were considered classifiable according to Clark's levels, out of these 165 were submitted to immediate node dissection. Neither level III nor level IV cases showed higher survival rate after immediate node dissection. Maximum tumor thickness according to Breslow was evaluated in 338 cases; 188 were submitted to wide excision and immediate node dissection. In no clusters of thickness did the enlarged surgical procedure achieve better results. The authors conclude that there is good evidence that in stage I melanoma of the extremities delayed dissection is as effective as the immediate one in the control of the disease if the patient can be kept under strict clinical control. Immediate node dissection is advisable if the quarterly follow-up is not guaranteed, at least for melanomas thicker than 2 mm.

UR - http://www.scopus.com/inward/record.url?scp=0019308719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019308719&partnerID=8YFLogxK

M3 - Article

C2 - 7003869

AN - SCOPUS:0019308719

VL - 66

SP - 373

EP - 396

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 3

ER -